Next Article in Journal
Osmotic Stress Blocks Mobility and Dynamic Regulation of Centriolar Satellites
Next Article in Special Issue
Dichloroacetate Affects Mitochondrial Function and Stemness-Associated Properties in Pancreatic Cancer Cell Lines
Previous Article in Journal
Endoplasmic Reticulum Stress in Metabolic Disorders
Previous Article in Special Issue
The Nutrient-Sensing Hexosamine Biosynthetic Pathway as the Hub of Cancer Metabolic Rewiring
Open AccessFeature PaperArticle

Hypoxia and IF1 Expression Promote ROS Decrease in Cancer Cells

Department of Biomedical and Neuromotor Sciences, Laboratory of Biochemistry and Mitochondrial Pathophysiology, University of Bologna, Bologna 40126, Italy
Department of Biomedical, Experimental, and Clinical Sciences “Mario Serio”, University of Florence, Florence 50121, Italy
Author to whom correspondence should be addressed.
Cells 2018, 7(7), 64;
Received: 25 May 2018 / Revised: 15 June 2018 / Accepted: 19 June 2018 / Published: 21 June 2018
(This article belongs to the Special Issue Mitochondrial Bioenergetics in Cancer Cell Biology)
The role of reactive oxygen species (ROS) in the metabolic reprogramming of cells adapted to hypoxia and the interplay between ROS and hypoxia in malignancy is under debate. Here, we examined how ROS levels are modulated by hypoxia in human cancer compared to untransformed cells. Short time exposure (20 min) of either fibroblasts or 143B osteosarcoma cells to low oxygen tension down to 0.5% induced a significant decrease of the cellular ROS level, as detected by the CellROX fluorescent probe (−70%). Prolonging the cells’ exposure to hypoxia for 24 h, ROS decreased further, reaching nearly 20% of the normoxic value. In this regard, due to the debated role of the endogenous inhibitor protein (IF1) of the ATP synthase complex in cancer cell bioenergetics, we investigated whether IF1 is involved in the control of ROS generation under severe hypoxic conditions. A significant ROS content decrease was observed in hypoxia in both IF1-expressing and IF1- silenced cells compared to normoxia. However, IF1-silenced cells showed higher ROS levels compared to IF1-containing cells. In addition, the MitoSOX Red-measured superoxide level of all the hypoxic cells was significantly lower compared to normoxia; however, the decrease was milder than the marked drop of ROS content. Accordingly, the difference between IF1-expressing and IF1-silenced cells was smaller but significant in both normoxia and hypoxia. In conclusion, the interplay between ROS and hypoxia and its modulation by IF1 have to be taken into account to develop therapeutic strategies against cancer. View Full-Text
Keywords: cancer cells; osteosarcoma; IF1; F1F0-ATPase; hypoxia; ROS; superoxide radical cancer cells; osteosarcoma; IF1; F1F0-ATPase; hypoxia; ROS; superoxide radical
Show Figures

Figure 1

MDPI and ACS Style

Sgarbi, G.; Gorini, G.; Liuzzi, F.; Solaini, G.; Baracca, A. Hypoxia and IF1 Expression Promote ROS Decrease in Cancer Cells. Cells 2018, 7, 64.

AMA Style

Sgarbi G, Gorini G, Liuzzi F, Solaini G, Baracca A. Hypoxia and IF1 Expression Promote ROS Decrease in Cancer Cells. Cells. 2018; 7(7):64.

Chicago/Turabian Style

Sgarbi, Gianluca; Gorini, Giulia; Liuzzi, Francesca; Solaini, Giancarlo; Baracca, Alessandra. 2018. "Hypoxia and IF1 Expression Promote ROS Decrease in Cancer Cells" Cells 7, no. 7: 64.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Search more from Scilit
Back to TopTop